An interventional study of A metacognitive group therapy of depression and anxiety in youth with autism in Anxiety Depression, sponsored by Uppsala University. Recruiting at 1 site in Sweden. Open to participants aged 15 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-09-29.
Sponsored by Uppsala University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Depression by Uppsala University — 5 open to participants now, 5 under way, none of them phase 3. Depression · Uppsala University.
Among the 17 studies in Depression by Uppsala University, this one is the 9th largest by planned enrollment of the 13 interventional ones that give a count, is one of 4 that started in 2024, is one of 12 with no phase, and was the 13th registered.
8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.
Browse Depression studies →5 of the 17 studies in Depression by Uppsala University are open now, in 1 country. Recruiting first, the newest first:
Uppsala University · Sites in Sweden
Ages 18–55
Uppsala University · Sites in Sweden
Ages 65+
Uppsala University · Sites in Sweden
Ages 18+ · Women only
Uppsala University · Sites in Sweden
Ages 15–29 · Healthy volunteers
By country, each count listing its studies:
Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.
This study: 15 Years to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 1998; this study’s year is marked. 4 started in 2024.
This study's planned enrollment of 36 is below the median of 81 across 7,089 interventional studies indexed under Depression.
Median enrollment 60 across the 13 interventional studies, 3,000 across the 3 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Uppsala University is the lead sponsor of 390 studies on the registry; 86 are open to participants now.
2 of the studies in Depression by Uppsala University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07706816Uppsala UniversityEvaluation of a Remote Behavioural Stress Recovery Intervention for Myocardial Infarction Patients Younger Than Fifty-five (BRIM-55): A Feasibility Study | 2027-01-31 |
| NCT06490120Uppsala UniversityA Study on Young Individuals' Mental Health in Sweden | 2027-03-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 17 studies in Depression by Uppsala University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this open clinical trial is to try out and evaluate a group metacognitive treatment protocol, for adolescents aged 15-18 years of age with anxiety and/or depression and an autism diagnosis.
The main questions it aims to answer are:
What are the preliminary effects of the treatment regarding
The participants will partake in metacognitive group treatment of 10 sessions following an initial screening.
Participants in the study are youth (15 to 18 years of age) seeking help for anxiety and depression within child and youth psychiatry. There will a consecutive inclusion to form 6 treatment groups with 6 persons in each. The groups will meet once every week. Assessments will take place at pre- and post-treatment as well as at 6-month follow-up. Some metacognitive processes will also be monitored at each group session. The therapists have undergone a specialist training in metacognitive therapy and are experienced in using the methods. The main focus of the study is on feasibility, acceptability and preliminary effects of the treatment. These will be analyzed with paired sample t-test on primary and secondary outcomes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A within group design where one clinical manualized intervention, Metacognitive therapy (MCT) for anxiety and depression, is offered in a 10-session group format to adolescents. The therapists have received special training in MCT and are experienced in using the methods. The treatment is delivered face-to-face.
Behavioral: A metacognitive group therapy of depression and anxiety in youth with autism
The treatment model is based on Adrian Wells' transdiagnostic A-M-C model and treatment structure described in Wells (2009) "Metacognitive therapy for anxiety and depression". The group treatment is delivered in 10 weekly sessions.
Revised Children's Anxiety and Depression Scale (RCADS)
A self-report that measures symptoms of anxiety and depression.
Time frame: Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up
Brunnsviken Brief Quality of life questionnaire (BBQ)
Measure of quality of life with a total score ranging from 0 to 96 with a higher score indicating a higher quality of life. The scores of each of the six primary questions regarding perceived quality of life within an area of life are multiplied with the score of an item measuring the perceived importance of the area in question.
Time frame: Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up
Metacognitions Questionnaire - 30 items version (MCQ-30)
A self-report measuring metacognitive assumptions and processes.
Time frame: Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up
Cognitive Attentional Syndrome Scale (CAS-1)
A self-report measuring the presence of Cognitive Attentional Syndrome
Time frame: Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up
Child Sheehan Disability Scale (CSDS)
A subjective appraisal of functional impairment related to familial, social and vocational aspects of life.
Time frame: Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up
Perceived Stress Scale 10 (PSS-10)
A questionnaire that aims to measure symptoms of stress. It contains 10 items that are scored on a range between 0 (never) to 4 (very often). The total score range is between 0-40 and a higher score reflects higher levels of perceived stress.
Time frame: Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up.
Negative Effects Questionnaire, 20 items Child (NEQ 20C)
A self-report measuring negative effects of the treatment and some aspects related to acceptability.
Time frame: After treatment completion at 10 weeks.
Started Aug 2024 (actual). Primary completion is estimated for Aug 2026, 24 months after the start.
Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 24 months is above that.
Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.